Page last updated: 2024-11-04

carbamylhydrazine and Leukemia

carbamylhydrazine has been researched along with Leukemia in 1 studies

carbamylhydrazine: RN given refers to parent cpd

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chiou, JT1
Shi, YJ1
Lee, YC1
Wang, LJ1
Chen, YJ1
Chang, LS1

Other Studies

1 other study available for carbamylhydrazine and Leukemia

ArticleYear
Carboxyl group-modified α-lactalbumin induces TNF-α-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis.
    International journal of biological macromolecules, 2021, Sep-30, Volume: 187

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Calcium Signaling

2021